Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms.
Gurban P, Mambet C, Botezatu A, Necula LG, Matei L, Neagu AI, Pitica I, Ataman M, Tatic A, Bardas A, Gaman MA, Dobrea C, Dragomir M, Ghimici C, Angelescu S, Barbu D, Stanca O, Danila M, Berbec N, Colita A, Vladareanu AM, Nedeianu S, Chivu-Economescu M, Bleotu C, Coriu D, Sepulchre E, Anton G, Diaconu CC, Constantinescu SN.
Gurban P, et al. Among authors: sepulchre e.
Am J Hematol. 2024 Oct 19. doi: 10.1002/ajh.27503. Online ahead of print.
Am J Hematol. 2024.
PMID: 39425629
No abstract available.